NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 16,943,774 Value ($000) $594,388 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 16,701,956 Value ($000) $475,004 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 16,607,074 Value ($000) $300,754 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 16,116,418 Value ($000) $329,903 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 15,916,418 Value ($000) $409,052 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 12,855,194 Value ($000) $213,396 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 12,226,943 Value ($000) $234,880 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 12,226,943 Value ($000) $289,167 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 12,131,705 Value ($000) $135,511 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 12,131,705 Value ($000) $112,218 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 10,871,803 Value ($000) $129,266 Avg Close $13.27 Range $11.03 - $17.00
Q1 2023
Shares 9,341,551 Value ($000) $125,550 Avg Close $12.62 Range $9.50 - $18.70
Q4 2022
Shares 9,341,551 Value ($000) $101,823 Avg Close $9.95 Range $7.52 - $32.88